Differential Hm antigen expression on EC cells and early differentiated derivatives

Area of Science:

• Immunology
• Developmental Biology
• Cancer Research

Background:

• Minor histocompatibility (Hm) alloantigens play a crucial role in T-cell mediated immune responses, particularly in transplantation and cancer immunity.
• Embryonal carcinoma (EC) cells, derived from germ cell tumors, share developmental similarities with early embryonic cells, making them a model for studying antigen expression during differentiation.
• Understanding Hm antigen expression on EC cells is vital for assessing their immunogenicity and potential as targets for cancer immunotherapy.

Purpose of the Study:

• To investigate and compare the expression and immunogenicity of minor histocompatibility (Hm) alloantigens on two mouse embryonal carcinoma (EC) cell lines (F9 and PCC3) and their differentiated derivatives (PYS-2 and T.D.M.-1).
• To elucidate the differences in Hm antigen presentation between EC cells and their differentiated counterparts, and their impact on cytolytic T-lymphocyte (CTL) responses.
• To explore the unexpected ability of some EC cell lines to compete for CTL effectors despite lacking major histocompatibility complex (MHC) products.

Main Methods:

• Utilizing various mouse responder-target strain combinations to assess CTL responses against EC cells and their derivatives.
• Employing Recombinant Inbred (RI) mouse strains to dissect the genetic basis of Hm antigen expression.
• Conducting in vivo priming experiments and in vitro cold target competition assays to evaluate Hm antigen immunogenicity and presentation by EC cell lines.

Main Results:

• Significant differences in Hm alloantigen expression were observed between EC cell lines and their differentiated derivatives, with the latter resembling adult splenocytes.
• Both EC cell lines exhibited reduced Hm immunogenicity compared to adult splenocytes.
• Distinct differences in Hm antigen expression and presentation were detected between the F9 and PCC3 EC cell lines, evident through in vivo and in vitro assays.

Conclusions:

• EC cells display a unique pattern of Hm alloantigen expression distinct from their differentiated progeny.
• The immunogenicity of EC cells is generally lower than that of adult splenocytes, with notable variations between different EC cell lines.
• EC cells can exhibit specific competition effects for CTLs, even in the absence of MHC products, highlighting complex immune evasion or recognition mechanisms.